Margaux Fresnais

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Drug Administration

Liquid Chromatography

Mass Spectrometry

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Margaux Fresnais, Siwen Liang, Deniz Seven, Nevena Prodanovic, Julia Sundheimer, Walter Emil Haefeli, Juergen Burhenne, Rémi Longuespée
Desorption Kinetics Evaluation for the Development of Validated Desorption Electrospray Ionization-Mass Spectrometric Assays for Drug Quantification in Tissue Sections. International journal of molecular sciences 24 (10) (2023)
Margaux Fresnais, Ina Jung, Uli B Klein, Aubry K Miller, Şevin Turcan, Walter Emil Haefeli, Juergen Burhenne, Rémi Longuespée
Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2'-Deoxyguanosine Methylations in DNA. Cancers 15 (3) (2023)
Margaux Fresnais, Ina Jung, Uli B Klein, Aubry K Miller, Şevin Turcan, Walter Emil Haefeli, Juergen Burhenne, Rémi Longuespée
Important Requirements for Desorption/Ionization Mass Spectrometric Measurements of Temozolomide-Induced 2'-Deoxyguanosine Methylations in DNA. Cancers 15 (3) (2023)
Margaux Fresnais, Siwen Liang, Marius Breitkopf, Joshua Raoul Lindner, Emmanuelle Claude, Steven Pringle, Pavel A Levkin, Konstantin Demir, Julia Benzel, Julia Sundheimer, Britta Statz, Kristian W Pajtler, Stefan M Pfister, Walter E Haefeli, Juergen Burhenne, Rémi Longuespée
Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue Sections. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Margaux Fresnais, Seda Karabulut, Yasmin Abou Zeed, Johannes Ungermann, Julia Benzel, Kristian W Pajtler, Stefan M Pfister, Walter Emil Haefeli, Juergen Burhenne, Rémi Longuespée
Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices-A Practical Example. Molecules (Basel, Switzerland) 27 (3) (2022)
Rémi Longuespée, Dirk Theile, Inka Zörnig, Jessica C Hassel, Joshua Raoul Lindner, Walter E Haefeli, Margaux Fresnais
Molecular prediction of clinical response to anti-PD-1/anti-PD-L1 immune checkpoint inhibitors: New perspectives for precision medicine and mass spectrometry-based investigations. International journal of cancer (2022)
Arman Kulyyassov, Margaux Fresnais, Rémi Longuespée
Targeted liquid chromatography-tandem mass spectrometry analysis of proteins: Basic principles, applications, and perspectives. Proteomics (2021)
Margaux Fresnais, Sevin Turcan, Dirk Theile, Johannes Ungermann, Yasmin Abou Zeed, Joshua Raoul Lindner, Marius Breitkopf, Juergen Burhenne, Walter Emil Haefeli, Rémi Longuespée
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma. Biomedicines 10 (1) (2021)
Rémi Longuespée, Dirk Theile, Margaux Fresnais, Juergen Burhenne, Johanna Weiss, Walter Emil Haefeli
Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. British journal of clinical pharmacology 87 (3) (2020)
Margaux Fresnais, Walter E Haefeli, Jürgen Burhenne, Rémi Longuespée
Rapid drug detection in whole blood droplets using a desorption electrospray ionization static profiling approach - a proof-of-concept. Rapid communications in mass spectrometry : RCM 34 (6) (2020)
Margaux Fresnais, André Roth, Kathrin I Foerster, Dirk Jäger, Stefan M Pfister, Walter Emil Haefeli, Juergen Burhenne, Rémi Longuespée
Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI-IM-MS/MS Assay. Cancers 12 (7) (2020)
Alexandra Russo, Claudia Paret, Francesca Alt, Jürgen Burhenne, Margaux Fresnais, Wolfgang Wagner, Martin Glaser, Hannah Bender, Sabrina Huprich, Patrick N Harter, Katharina Filipski, Nadine Lehmann, Nora Backes, Lea Roth, Larissa Seidmann, Clemens Sommer, Marc A Brockmann, Torsten Pietsch, Marie A Neu, Arthur Wingerter, Joerg Faber
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor. International journal of molecular sciences 20 (17) (2019)